IOBT vs RUN · $98.2M cap vs P/E 6.0, rev $1.59B
IO Biotech Inc (IOBT) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
IO Biotech Inc (IOBT) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
IOBT does not have a complete income-statement cache yet.
Latest reported RUN revenue for 2026-06-30 was $1.59B. Net income was $282.8M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
IOBT currently screens at market cap $98.2M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the IOBT and RUN stock pages for the full models.
Not investment advice.